The Goldman Sachs Group upgraded shares of GE HealthCare Technologies (NASDAQ:GEHC – Free Report) from a neutral rating to a buy rating in a research note published on Tuesday morning, MarketBeat ...
Goldman Sachs upgrades GE Healthcare to Buy, raising its price target to $100, as analysts see market stabilization and China ...
GE HealthCare Technologies Inc. GEHC has recently unveiled the Genesis portfolio, a portfolio of cloud enterprise imaging ...
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $104.0, a high estimate of $110.00, and a low estimate of $100.00. Observing a 9.76 ...
Fintel reports that on March 11, 2025, Goldman Sachs upgraded their outlook for GE HealthCare Technologies (NasdaqGS:GEHC) ...
Goldman Sachs upgraded GE HealthCare (GEHC) to Buy from Neutral with a price target of $100, up from $85. The firm’s confidence in the outlook ...
Shares of GE HealthCare Technologies Inc. GEHC slid 1.41% to $85.36 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 2.70% to ...